Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zijun Ma
Institutions:
Hubei University of Medicine,
Fujian Medical University,
China National Pharmaceutical Group Corporation (China),
Dongfeng General Hospital,
Tongji Hospital,
Union Hospital,
Huazhong University of Science and Technology
show all 7
Observed institutions:
Hubei University of Medicine,
Fujian Medical University,
China National Pharmaceutical Group Corporation (China),
Dongfeng General Hospital,
Tongji Hospital,
Union Hospital,
Huazhong University of Science and Technology
show all 7
ORCID:
0009-0007-1327-435X
Observed ORCID:
0009-0007-1327-435X
OpenAlex ID:
A5034385362
Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials
2022
·
Zijun Ma
, Jun Chen
, et al.
·
Frontiers in Cardiovascular Medicine
·
43
The functions of apolipoproteins and lipoproteins in health and disease
2024
·
Zijun Ma
, Jixin Zhong
, et al.
·
Molecular Biomedicine
·
41
Research Progress on the GIP/GLP-1 Receptor Coagonist Tirzepatide, a Rising Star in Type 2 Diabetes
2023
·
Zijun Ma
, Kaiqin Jin
, et al.
·
Journal of Diabetes Research
·
29
The Role of Cardiac Macrophages in Inflammation and Fibrosis after Myocardial Ischemia-Reperfusion
2024
·
Kaiqin Jin
, Zijun Ma
, et al.
·
Reviews in Cardiovascular Medicine
·
18
PDF
The correlation between the atherogenic index of plasma and the severity of coronary artery disease in acute myocardial infarction patients under different glucose metabolic states
2025
·
Kaiqin Jin
, Zijun Ma
, et al.
·
Scientific Reports
·
10
PDF
Less is more: hematologic safety and sustained efficacy of a modified low‐dose etoposide regimen in macrophage activation syndrome
2025
·
Zijun Ma
, Yingying Wei
, et al.
·
Arthritis & Rheumatology
·
1
Show more works
View as search
Works count:
6
Citation count:
142
H-index:
5
I10-index:
5
Year
Topic
Type